Sunitinib 50 mg (Generic)

What is Sunitinib 50 mg?

Sunitinib 50 mg is a prescription medication primarily used to treat certain types of cancers, including kidney cancer and gastrointestinal stromal tumors (GIST). Manufactured by Natco Pharma Ltd., it offers patients an effective option for managing their disease under medical supervision. The medication’s active ingredient, Sunitinib, is widely recognized for its targeted action against cancer cells.

This medication belongs to a class of drugs known as tyrosine kinase inhibitors. It functions by blocking specific enzymes involved in the growth and proliferation of cancer cells, thereby slowing down or stopping tumor progression. Sunitinib 50 mg is administered orally and is an essential part of treatment protocols prescribed by oncologists.

Approved for use in various countries including Malaysia, Sunitinib 50 mg is an important medicine for patients with advanced or metastatic kidney cancer and gastrointestinal stromal tumors that are not responsive to other treatments. Its availability from trusted manufacturers such as Natco Pharma Ltd. ensures quality and safety standards.

Patients prescribed Sunitinib 50 mg should follow their healthcare provider’s guidance carefully to achieve the best results while minimizing potential side effects. Continuous monitoring and regular check-ups are recommended during treatment.

Uses of Sunitinib 50 mg

• Treatment of advanced renal cell carcinoma (kidney cancer)
• Management of gastrointestinal stromal tumors (GIST) resistant to imatinib
• Therapy for pancreatic neuroendocrine tumors
• Used in certain cases of progressive or metastatic cancers as advised by a physician

How Sunitinib 50 mg Works

Sunitinib 50 mg acts by inhibiting multiple receptor tyrosine kinases (RTKs) which play a crucial role in cancer cell growth and angiogenesis – the formation of new blood vessels that tumors need for survival. By blocking these RTKs, the drug starves the tumor of its blood supply and impedes cellular proliferation. This targeted mechanism helps reduce tumor size and control cancer spread.

The focus on specific enzymes allows Sunitinib to work selectively against cancer cells, lessening damage to normal, healthy cells compared to conventional chemotherapy. This targeted approach is a cornerstone in modern cancer therapeutics.

How to take Sunitinib 50 mg

Sunitinib 50 mg should be taken exactly as prescribed by your healthcare provider. The medication is usually taken once daily, on an empty stomach, at least one hour before or two hours after a meal.

It is important not to skip doses, and if you miss a dose, take it as soon as you remember unless it is near the time of your next scheduled dose. Do not double up doses to compensate for a missed one. Regular blood tests and health assessments may be required to monitor your response and side effects.

Benefits of Sunitinib 50 mg

• Targets specific cancer pathways to inhibit tumor growth
• Reduces tumor blood supply via anti-angiogenic effects
• Offers an oral treatment alternative to intravenous chemotherapy
• Effective in managing advanced kidney cancer and GIST
• Improves progression-free survival in many patients

Dosage and Administration

The usual recommended dose of Sunitinib 50 mg is one 50 mg capsule once daily for four consecutive weeks followed by a two-week rest period, constituting a six-week treatment cycle. However, dosing may be adjusted based on individual tolerance, response, and treatment plan set by the oncologist.

Patients should never adjust the dose or discontinue treatment without consulting their healthcare provider. Dose modifications may be necessary in cases of severe side effects or other medical conditions.

Who Should Use Sunitinib 50 mg?

Sunitinib 50 mg is prescribed for adults diagnosed with:

• Locally advanced or metastatic renal cell carcinoma (kidney cancer)
• Gastrointestinal stromal tumors that are resistant or intolerant to imatinib
• Pancreatic neuroendocrine tumors requiring targeted therapy

Only patients with medical clearance from an oncologist or authorized healthcare professional should use this medication.

Who Should Avoid Sunitinib 50 mg?

Sunitinib 50 mg is not recommended for individuals who:

• Have a known hypersensitivity to Sunitinib or any components of the capsule
• Are pregnant or planning to become pregnant due to potential harm to the fetus
• Are breastfeeding women
• Have severe hepatic impairment or uncontrolled cardiovascular disease without medical supervision
• Are currently taking medications known to interact adversely with Sunitinib without doctor’s guidance

Side Effects of Sunitinib 50 mg

• Fatigue or tiredness
• Nausea and vomiting
• Diarrhea
• Mouth sores or stomatitis
• High blood pressure (hypertension)
• Skin discoloration or rash
• Hand-foot syndrome (redness and peeling of palms or soles)
• Decreased appetite
• Hair thinning or hair loss
• Fever
• Abdominal pain or discomfort
• Changes in taste

Safety Advice

• Inform your doctor of all existing health conditions before starting treatment
• Report any unusual symptoms or severe side effects promptly
• Avoid pregnancy during and at least 4 weeks after treatment; use effective contraception
• Do not consume grapefruit or grapefruit juice while taking Sunitinib
• Regularly monitor blood pressure and blood counts as advised
• Avoid driving or operating heavy machinery if feeling dizzy or fatigued
• Store medication out of reach of children

Drug Interactions

• Medications that affect liver enzymes CYP3A4 (e.g., ketoconazole, rifampin)
• Blood thinners such as warfarin
• Drugs that increase blood pressure
• Certain antidepressants and anticonvulsants
• Other cancer therapies without doctor’s approval

Storage Instructions

Store Sunitinib 50 mg capsules at room temperature between 20°C and 25°C (68°F to 77°F). Keep the medication in its original container, tightly closed, and protect it from moisture and light. Do not store in the bathroom or areas with high humidity. Keep out of reach of children and pets.

Where to buy Sunitinib 50 mg in Malaysia?

In Malaysia, Sunitinib 50 mg is available through licensed pharmacies and authorized medical suppliers. Always purchase from reputable sources to ensure product authenticity and quality. It is essential to have a valid prescription from a certified healthcare professional before buying this medication. Some hospitals and oncology centers may assist in obtaining Sunitinib 50 mg as part of your treatment plan.

Frequently Asked Questions (FAQ)

What is the price of Sunitinib 50 mg in Malaysia?

The price of Sunitinib 50 mg may vary depending on the pharmacy or supplier. It is advisable to check with authorized pharmacies or healthcare providers in Malaysia for the most accurate pricing.

What happens if I miss a dose?

If you miss a dose, take it as soon as you remember unless it is near the time for your next dose. Do not double the dose to make up for the missed one. Contact your doctor if you are unsure.

Where can I find Sunitinib 50 mg for sale?

Sunitinib 50 mg is available at licensed pharmacies and oncology treatment centers in Malaysia. A valid prescription is required to purchase this medicine legally and safely.

Is Sunitinib 50 mg available in Malaysia?

Yes, Sunitinib 50 mg is available in Malaysia through authorized pharmaceutical distributors and healthcare providers. Ensure you buy it from reputable sources to guarantee product quality.

Can I take Sunitinib 50 mg with other medications?

You should inform your doctor about all medicines you are currently taking. Sunitinib may interact with other drugs, so your healthcare provider will evaluate the safety and provide guidance accordingly.

How long does it take for Sunitinib 50 mg to work?

The response time can vary depending on individual health conditions and cancer type. Generally, treatment effectiveness is evaluated after several weeks or treatment cycles through medical imaging and tests.

Are regular blood tests necessary during treatment?

Yes, regular blood tests and monitoring are essential while on Sunitinib 50 mg to track side effects and adjust dosage if needed.

Conclusion

Sunitinib 50 mg by Natco Pharma Ltd. provides a targeted cancer treatment option especially beneficial for patients with kidney cancer and gastrointestinal stromal tumors. Its mechanism focuses on inhibiting tumor growth and angiogenesis, helping control disease progression. When used responsibly under medical supervision, Sunitinib 50 mg enhances treatment outcomes and offers hope for managing challenging cancers. Always consult your healthcare provider for personalized advice and ensure to purchase from trusted sources to guarantee safety and efficacy.